Aduro Biotech Names Industry Veteran And Academic Leader, Gerald Chan, DSc To Its Board Of Directors

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc., a clinical-stage biotechnology company, today announced that renowned academic leader and industry veteran, Gerald Chan, DSc has joined its board of directors. Dr. Chan is the co-founder of Morningside, a private investment group with venture, private equity and property investments.

In the life science sector, Morningside focuses on start-up biotechnology companies founded on novel scientific discoveries. Dr. Chan serves on the boards of Advanced Cell Diagnostics, Oxyrane, Stealth Peptides, Synchroneuron, Apellis, Nucana, VTI and Matrivax.

Help employers find you! Check out all the jobs and post your resume.